BioDuro, a leading global contract, research, development and manufacturing organization (CRDMO), is proud to announce its win at the Outsourced Pharma 2025 CDMO Leadership Awards. This honor recognizes BioDuro's excellence in pharmaceutical development and manufacturing.
The awards celebrate top CDMOs as rated by customers who have utilized their services in the past 24 months. BioDuro’s win highlights its commitment to high-quality solutions that meet industry needs. The company was recognized in the following categories: Small Molecule API - Global and Small Molecule Dosage Form - Global.
“We are honored to receive this award,” said Armin Spura, CEO at BioDuro. “This reflects our team’s dedication to innovation and exceptional service in drug development and manufacturing.”
With seven global campuses, BioDuro offers end-to-end services from preclinical development to commercial manufacturing, helping bring life-saving therapies to market faster.
The award will be recognized at the Outsourced Pharma's CDMO Leadership Awards Ceremony on March 19 in New York City. BioDuro remains committed to being a trusted partner for pharmaceutical and biotech companies worldwide.
For more about BioDuro and its CDMO services,visit https://www.bioduro.com
About BioDuro
BioDuro is a global CDMO specializing in drug discovery, development, and manufacturing. With seven campuses and a commitment to scientific excellence, BioDuro accelerates innovative therapies. Visit www.bioduro.com for more information.
Home